Modulus is engineering next-generation immune cell therapies, starting with Natural Killer cells rationally designed for the treatment of solid tumors.
Location: United States, Washington, Seattle
Total raised: $3.5M
Investors 2
| Date | Name | Website |
| - | KdT Ventur... | kdtvc.com |
| 16.07.2021 | Madrona Ve... | madrona.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.07.2021 | Seed | $3.5M | - |
Mentions in press and media 2
| Date | Title | Description | Source |
| 15.07.2021 | Modulus, a cell therapy biotech incubated at the Allen Insti... | Human natural killer cell. (National Institute of Allergy and Infectious Diseases Image) Modulus Th... | geekwire.c... |
| 15.07.2021 | Modulus Therapeutics Secures $3.5 Million Seed Funding for A... | Seattle-based AI hot startup, Modulus Therapeutics has announced it completed an oversubscribed $3.5... | aithority.... |